Laboratory screening for cervical tumor sensitivity to cisplatin could lead to individualized treatment of cervical cancers and better outcomes, suggest the authors of a small study published ...

I was diagnosed with stage 4 cervical cancer at 21 — the symptoms that made me get checked By . Tracy Swartz. Published Feb. 4, 2025, 6:00 a.m. ET.

KEYTRUDA plus chemoradiotherapy is the first anti-PD-1-based regimen approved in the EU for patients with FIGO 2014 Stage III-IVA locally advanced cervical cancer.